Clinical Trials Browser

Withdrawn × Endometrial Neoplasms × Axitinib × Clear all

NCT04197219 2020-11-05

Pembrolizumab With Axitinib in Recurrent Endometrial Cancer

Phase 2 Withdrawn

Endometrial Neoplasms